Drugs made from magic mushrooms could help treat depression, says study.
Scientists believe that the chemical psilocybin, the psychedelic ingredient in magic mushrooms, can turn down parts of the brain that are overactive in severely depressive patients, the Guardian reported.
Depression Symptom Evaluation
Depression occurs due to alterations in the levels of neurotransmitters in the brain.
Advertisement
The drug appears to stop patients dwelling on themselves and their own perceived inadequacies.
However, a bid by British scientists to carry out trials of psilocybin on patients in order to assess its full medical potential has been blocked by red tape relating to Britain's strict drugs laws.
![Depression]( "Depression")
Depression is one of the most common mental disorders affecting approximately 340 million people in the world. No one is immune from depression - it occurs in people of all social classes, all countries and all cultural settings.
Professor David Nutt, professor of neuropsychopharmacology at Imperial College London, said that because magic mushrooms are rated as a class-A drug, their active chemical ingredient cannot be manufactured unless a special licence is granted.
"We haven't started the study because finding companies that could manufacture the drug and who are prepared to go through the regulatory hoops to get the licence is proving very difficult," Nutt said.
"The whole field is so bedevilled by primitive old-fashioned attitudes. Even if you have a good idea, you may never get it into the clinic, it seems," he added.
Research by Nutt has found that psilocybin switches off part of the brain called the anterior cingulate cortex.
It was known that this area is overactive in individuals suffering from depression.
In his tests on healthy individuals, it was found that psilocybin had a profound effect on making these volunteers feel happier weeks after they had taken the drug, Nutt said.
Source: ANI
Depression
Depression is one of the most common mental disorders affecting approximately 340 million people in the world. No one is immune from depression - it occurs in people of all social classes, all countries and all cultural settings.
Advertisement
Professor David Nutt, professor of neuropsychopharmacology at Imperial College London, said that because magic mushrooms are rated as a class-A drug, their active chemical ingredient cannot be manufactured unless a special licence is granted.
"We haven't started the study because finding companies that could manufacture the drug and who are prepared to go through the regulatory hoops to get the licence is proving very difficult," Nutt said.
"The whole field is so bedevilled by primitive old-fashioned attitudes. Even if you have a good idea, you may never get it into the clinic, it seems," he added.
Research by Nutt has found that psilocybin switches off part of the brain called the anterior cingulate cortex.
It was known that this area is overactive in individuals suffering from depression.
In his tests on healthy individuals, it was found that psilocybin had a profound effect on making these volunteers feel happier weeks after they had taken the drug, Nutt said.
Source: ANI
Quiz on Depression
The World Health Organization reports that depression is one of the main causes of disability affecting about 121 million people worldwide. More tragically, it claims around 850,000 lives every year. Hence, it is important that we understand this affliction to help ourselves or our loved ones to cope and, hopefully, resolve it. How well do you know the facts about depression? Take this quiz and f
Advertisement
 Mushroom Poison to Arrest Pancreatic Cancer: StudyIn mice, amanitin - toxin found in death cap mushroom Amanita phalloides destroys pancreatic cancer cells without harming the body, say researchers | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
